Robert Wasserman
Stock Analyst at StoneX
(4.37)
# 1,326
Out of 5,152 analysts
202
Total ratings
46%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: KMDA Kamada Ltd. | Reiterated: Buy | ILA 4,789 | ILA 2,645 | +81.05% | 6 | Sep 18, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $220 → $335 | $293.81 | +14.02% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $162.18 | +14.07% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Reiterated: Buy | $91 | $64.29 | +41.55% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.63 | - | 18 | Jun 30, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $90 | $95.97 | -6.22% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Reiterated: Hold | n/a | $1.07 | n/a | 16 | Nov 14, 2025 | |
| OABI OmniAb | Reiterated: Buy | $6 → $4 | $5.05 | n/a | 11 | Nov 6, 2025 | |
| INTS Intensity Therapeutics | Reiterated: Buy | $38 | $2.67 | n/a | 7 | Oct 31, 2025 | |
| ABCL AbCellera Biologics | Reiterated: Hold | n/a | $11.03 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.90 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.61 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9067 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $1.87 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $686.79 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $225.77 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.59 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $80 | $1.73 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.82 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.85 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.33 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $4.10 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $1.72 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.4884 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.21 | n/a | 1 | Mar 12, 2013 |
Kamada Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: ILA 4,789
Current: ILA 2,645
Upside: +81.05%
Ligand Pharmaceuticals
Jul 16, 2026
Reiterated: Buy
Price Target: $220 → $335
Current: $293.81
Upside: +14.02%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $162.18
Upside: +14.07%
Proto Labs
Jul 6, 2026
Reiterated: Buy
Price Target: $91
Current: $64.29
Upside: +41.55%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.63
Upside: -
Halozyme Therapeutics
Feb 19, 2026
Reiterated: Buy
Price Target: $90
Current: $95.97
Upside: -6.22%
Codexis
Nov 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.07
Upside: n/a
OmniAb
Nov 6, 2025
Reiterated: Buy
Price Target: $6 → $4
Current: $5.05
Upside: n/a
Intensity Therapeutics
Oct 31, 2025
Reiterated: Buy
Price Target: $38
Current: $2.67
Upside: n/a
AbCellera Biologics
Aug 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.03
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $5
Current: $2.90
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $12
Current: $5.61
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $3
Current: $0.9067
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $1.87
Upside: n/a
Oct 26, 2023
Reiterated: Hold
Price Target: n/a
Current: $686.79
Upside: n/a
Oct 25, 2023
Reiterated: Hold
Price Target: n/a
Current: $225.77
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.59
Upside: n/a
Apr 4, 2023
Reiterated: Buy
Price Target: $9 → $80
Current: $1.73
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $1.82
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.85
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.33
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $4.10
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $1.72
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.4884
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $6.21
Upside: n/a